Clinical Trial Update: Clinical Study of Lyophilized Plasma in Patients With Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating lyophilized plasma for liver disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Lyophilized Plasma

Snippet

Sponsor: HemCon Medical Technologies, Inc | Conditions: Liver Disease | Phase 2 | Status: WITHDRAWN